Clovis Oncology (CLVS) Prices 3.75M Offering at $20/Share
Get Alerts CLVS Hot Sheet
Join SI Premium – FREE
Clovis Oncology, Inc. (Nasdaq: CLVS) announces the pricing of its underwritten public offering of 3,750,000 shares of its common stock at $20.00 per share, before underwriting discounts and commissions.
In addition, the underwriters have a 30-day option to purchase up to an additional 562,500 shares of common stock from Clovis Oncology to cover over-allotments, if any.
The offering is expected to close on April 10, 2012, subject to customary closing conditions.
In addition, the underwriters have a 30-day option to purchase up to an additional 562,500 shares of common stock from Clovis Oncology to cover over-allotments, if any.
The offering is expected to close on April 10, 2012, subject to customary closing conditions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tonix Pharma (TNXP) Prices $4.4 Million Registered Direct Offering
- SS&C Technologies (SSNC) Unveils Next-Gen Hybrid Intelligent Automation Platform
- FibroBiologics (FBLG) Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!